By Justin Petrone

Seeking to cash in on increased demand by pharmaceutical researchers in the US and China for next-generation protein-analysis tools, Plexera recently began selling its surface-plasmon-resonance PlexArray System to early-access customers in those countries.

The 1-year-old, rebuilt company, which has operations in Woodinville, Wash., and Beijing, also plans to formally debut the tool in the US and China, according to its president.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.